Mass Spectrometry

The Mass Spectrometry Facility houses cutting-edge mass spectrometry and proteomics technologies for the study of protein structure and function, and their relationship to human disease. The facility provides:

Based on a collaborative model:

  • Consultation to researchers interested in or engaged in biomarker identification, including basic protein identification, fractionation and anMass spectrometry alysis
  • Proteomic analyses for discovery studies, using in-gel and gel-free technologies
  • Design and development of Mass spectrometry-based research diagnostics and/or ELISA assays.

Based on a fee-for-service model:

  • A range of NATA certified assays for steroids, metanephrines, vitamins and drugs
  • Assay service for research groups.

Contact

Dr Andrew Stephens
Head, Ovarian Cancer Biomarker Laboratory
Hudson Institute
t:+61 3 8572 2686
e: andrew.n.stephens@hudson.org.au

Dr George Streitberg
Principal Scientist
Biochemistry
Monash Health
t:+61 3 9594 2055
e: george.streitberg@monashhealth.org